Table 1 Baseline demographics of participants
Variable | PTAa | TAUb | All |
|---|---|---|---|
(N = 94) | (N = 107) | (N = 201) | |
Mean (SD) | Mean (SD) | ||
Age at screening (year) | 59.86 (9.13) | 60.71 (10.26) | 60.31 (9.73) |
Gender | |||
Female | 34 (36.2%) | 45 (42.1%) | 79 (39.3%) |
Male | 60 (63.8%) | 62 (57.9%) | 122 (60.7%) |
Number of comorbidities | 1.39 (1.66) | 1.32 (1.59) | 1.35 (1.62) |
Parkinson’s disease duration (years) | 5.47 (4.18) | 5.47 (4.89) | 5.47 (4.56) |
Morisky Medication Adherence Scale (MMAS-8c) | 6.03 (1.57) | 5.82 (1.48) | 5.92 (1.52) |
Quality of life (PDQ-39) | 154.53 (27.98) | 151.43 (27.70) | 152.88 (27.81) |
Patient-Centered Questionnaire for Parkinson’s Disease (PCQ-PD) | 1.91 (0.53) | 1.93 (0.51) | 1.92 (0.52) |
Non-Motor Symptoms Questionnaire (NMSQuest) | 10.16 (5.42) | 10.24 (5.24) | 10.20 (5.31) |
Hospital Anxiety Rating Scale (HADSa) | 5.49 (3.95) | 6.16 (4.14) | 5.85 (4.06) |
Hospital Depression Rating Scale (HADSd) | 5.15 (3.68) | 5.14 (3.73) | 5.14 (3.70) |
Beliefs about Medication Questionnaire (BMQ) | 51.83 (9.48) | 51.93 (8.09) | 51.88 (8.74) |
Number who need help with their medication (n) | 19 | 27 | 46 |
